The impact of ESG performance on corporate innovation—Empirical evidence from Chinese pharmaceutical listed companies.
Saved in:
| Title: | The impact of ESG performance on corporate innovation—Empirical evidence from Chinese pharmaceutical listed companies. |
|---|---|
| Authors: | Li, Liqiang1 (AUTHOR), Wang, Su1,2 (AUTHOR) wangsu414@163.com, Chen, Yuwen1,2 (AUTHOR) chenyuwen@syphu.edu.cn |
| Source: | PLoS ONE. 11/4/2025, Vol. 20 Issue 11, p1-23. 23p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0332906 |
